Oregon lawmakers have heard more than a dozen bills so far this session on the pharmaceutical industry, many attempting to address skyrocketing costs.
A rare scene of drama erupted in a House health care committee hearing on Tuesday as the chair and a lobbyist for the pharmaceutical industry clashed over a fairly straightforward bill that would require greater transparency on the part of drug manufacturers.
A two-decade surge in opioid overdose deaths has prompted health officials, addiction specialists and the federal government to declare opioid addiction a public health emergency.
California Gov. Gavin Newsom says he’s done waiting for the federal government to curtail the rising cost of prescription drugs.
Newsom has his own plan to ease that financial burden — one he hopes other states can join or replicate.
Medicare patients with multiple sclerosis face skyrocketing costs for treatment due to insurance regulations that force them to pay more out of pocket for generic drugs, a study has found.